Cardiomyopathy future or investigational therapies: Difference between revisions
No edit summary |
Lina Yaqoub (talk | contribs) |
||
| Line 11: | Line 11: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
{{Effects of Intracoronary Stem Cell Transplantation in Patients With Dilated Cardiomyopathy Vrtovec, Bojan et al. Journal of Cardiac Failure , Volume 17 , Issue 4 , 272 - 281}} | |||
Revision as of 18:22, 16 December 2018
|
Cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Guidelines |
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy |
|
Case Studies |
|
Cardiomyopathy future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Cardiomyopathy future or investigational therapies |
|
Cardiomyopathy future or investigational therapies in the news |
|
Risk calculators and risk factors for Cardiomyopathy future or investigational therapies |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
References
Template:WH Template:WS Template:Effects of Intracoronary Stem Cell Transplantation in Patients With Dilated Cardiomyopathy Vrtovec, Bojan et al. Journal of Cardiac Failure , Volume 17 , Issue 4 , 272 - 281